DARMSTADT, Germany--(BUSINESS WIRE)--Merck Serono, a leader in personalizing cancer care, continues to drive the global effort to ensure patients receive therapies tailored to their cancer. This approach will be the focus of the forthcoming American Society of Clinical Oncology (ASCO) meeting in Orlando, Florida taking place from May 29 to June 2 2009. Seventy abstracts were accepted for inclusion.